ロード中...
Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study
BACKGROUND: Rifaximin has been shown to reduce the incidence of hepatic encephalopathy and other complications in patients with cirrhosis. However, few studies have investigated the effect of rifaximin in cirrhotic patients with refractory ascites. AIM: To evaluate the effects of rifaximin in the tr...
保存先:
| 出版年: | World J Gastroenterol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Inc
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6962437/ https://ncbi.nlm.nih.gov/pubmed/31988585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v26.i2.199 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|